Blocking the TLR4 or NF-κB pathway partially reversed the impaired osteogenic potential of PDLSCs after LPS treatment and prevented the alveolar bone loss induced by LPS in experimental periodontitis in rats. This evidence concerns the gene TLR4 and periodontitis.